195 related articles for article (PubMed ID: 6931871)
21. Lipid-lowering drugs.
Med Lett Drugs Ther; 1985 Aug; 27(695):74-6. PubMed ID: 3860714
[No Abstract] [Full Text] [Related]
22. [Clinical effects and tolerance of etofylline clofibrate].
Ziegler WJ; Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
24. Nutritional & pharmacologic management of hyperlipoproteinemia.
Pickering JE
Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
[TBL] [Abstract][Full Text] [Related]
25. Gemfibrozil therapy in patients with coronary heart disease.
Bell H; Dittmeier G; Martinez L
Mo Med; 1988 Jan; 85(1):27-30. PubMed ID: 3277032
[No Abstract] [Full Text] [Related]
26. The effect of gemfibrozil on serum lipids in diabetic patients.
Konttinen A; Kuisma I; Ralli R; Pohjola S; Ojala K
Ann Clin Res; 1979 Dec; 11(6):240-5. PubMed ID: 398183
[TBL] [Abstract][Full Text] [Related]
27. Gemfibrozil in a group of diabetics.
de Salcedo I; Gorringe AL; Silva JL; Santos JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
[TBL] [Abstract][Full Text] [Related]
28. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
Jones AF; Hughes EA; Cramb R
Lancet; 1988 Apr; 1(8588):776. PubMed ID: 2895309
[No Abstract] [Full Text] [Related]
29. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
Houlston R; Quiney J; Watts GF; Lewis B
J R Soc Med; 1988 May; 81(5):274-6. PubMed ID: 3164409
[TBL] [Abstract][Full Text] [Related]
30. Gemfibrozil, lipids, and coronary risk.
Rifkind BM
N Engl J Med; 1987 Nov; 317(20):1279-81. PubMed ID: 3313042
[No Abstract] [Full Text] [Related]
31. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Weintraub MS; Eisenberg S; Breslow JL
J Clin Invest; 1987 Apr; 79(4):1110-9. PubMed ID: 3470306
[TBL] [Abstract][Full Text] [Related]
32. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
Goranov I; Naumova R; Kerekovska M; Balabanski L
Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738
[TBL] [Abstract][Full Text] [Related]
33. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
34. The Gemfibrozil Study.
Manninen V
Acta Med Scand Suppl; 1985; 701():83-8. PubMed ID: 3907298
[TBL] [Abstract][Full Text] [Related]
35. Extrinsic factors affecting the response to gemfibrozil.
Huunan-Seppälä A; Manninen V; Burton R; Eisalo A
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154
[No Abstract] [Full Text] [Related]
36. [Gemfibrozil in the treatment of hyperlipoproteinemias].
Monova D; Petrova V; Belovezhdov N
Vutr Boles; 1991; 30(2):56-8. PubMed ID: 1891900
[TBL] [Abstract][Full Text] [Related]
37. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
38. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
Artery; 1981; 9(1):77-86. PubMed ID: 7018466
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
Sznajderman M
Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
[No Abstract] [Full Text] [Related]
40. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Rodney G; Uhlendorf P; Maxwell RE
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
